# Covishield – Asian Mirror

May 8, 2024 by: web admin

AstraZeneca Withdraws COVID-19 Vaccine Due to ‘Commercial Reasons’

ANS: AstraZeneca, the manufacturer of the Covishield COVID-19 vaccine, has announced its decision to withdraw the vaccine from circulation, citing “commercial reasons.” The company stated …

April 9, 2022 by: web admin

Covishield, Covaxin price cuts to Rs 225 per dose for private hospitals

ANS: The prices of Covid vaccine, COVISHIELD (Serum Institute) and COVAXIN (Bharat Biotech) have been slashed for private hospitals. The price of the Covishield vaccine …

March 20, 2022March 20, 2022 by: web admin

“Reduce Covishield vaccine gap” : NTAGI

ANS: Amidst rising COVID cases in European and few Asian countries, the National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between …

January 5, 2022 by: web admin

Intranasal vaccine gets nod for Phase 3 trials in India

ANS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on …

June 16, 2021 by: web admin

Single Covishield vaccine shot sufficient for recovered persons: Study

ANS: A single dose of Covishield Vaccine administered to those recovered from the infection with SARS-CoV-2 indicated these people were more immune against Covid-19 than …

June 4, 2021June 4, 2021 by: web admin

ESL organises ‘Covishield’ vaccination drive for its on-roll employees

RNS: ESL Steel Limited, a national steel manufacturer from the Vedanta Group, has organised a ‘Covishield’ vaccination drive for its on-roll employees. The week-long drive started …

May 26, 2021 by: web admin

No consensus yet at WHO level on the issue of “Vaccine Passport” : Govt.

# Bharat Biotech applies for WHO emergency use listing for Covaxin ASN: Rejecting the claims and media reports that “Vaccine Passport”— that the type of …

May 14, 2021May 14, 2021 by: Ashis Sinha

Covishield 2nd dose interval increases to 12-16 weeks

ANS: The government has increased the intervals between two doses of Covishield to 12 to 16 weeks from the existing 6 to 8 weeks on Thursday. …

May 12, 2021 by: web admin

Covaxin gets approval for phase 2, 3 trials on 2-18 year-olds

ANS: An expert panel on Tuesday recommended Covaxin (COVID-19 vaccine) for phase-2 and phase-3 clinical trial on younger population aged between 2 to 18 years, …

May 9, 2021 by: Ashis Sinha

Tools that help you to find COVID-19 vaccination slot

ANS: Vaccination against COVID-19 is now being attempted to be put to all people aged above 18 years. Walk-in vaccinations are not permitted for the …

ISRO’s Next Big Leap: 6,500-kg US Satellite Launch Set for Next Two Months from Indian Soil

ISRO’s Next Big Leap: 6,500-kg US Satellite Launch Set for Next Two Months from Indian Soil

Tag: # Covishield

AstraZeneca Withdraws COVID-19 Vaccine Due to ‘Commercial Reasons’

Covishield, Covaxin price cuts to Rs 225 per dose for private hospitals

“Reduce Covishield vaccine gap” : NTAGI

Intranasal vaccine gets nod for Phase 3 trials in India

Single Covishield vaccine shot sufficient for recovered persons: Study

ESL organises ‘Covishield’ vaccination drive for its on-roll employees

No consensus yet at WHO level on the issue of “Vaccine Passport” : Govt.

Covishield 2nd dose interval increases to 12-16 weeks

Covaxin gets approval for phase 2, 3 trials on 2-18 year-olds

Tools that help you to find COVID-19 vaccination slot